PHASE I STUDY OF NON-REPLICATING AUTOLOGOUS TUMOR CELL INJECTIONS 
USING CELLS PREPARED WITH OR WITHOUT GM-CSF GENE TRANSDUCTION IN 
PATIENTS WITH METASTATIC RENAL CELL CARCINOMA 
Investigators : 
Anton J.M. Berns, Ph.D. s 
Lawrence K. Cohen, Ph.D. 5 
Ross C. Donehower, M.D. 1 
Glen Dranoff, M.D. 3 
Karen M. Hauda, M.S. 1 
Elizabeth M. Jaffee, M.D. 1 
Audrey J. Lazenby, M.D. 4 
Hyam I. Levitsky, M.D. 1 
Fray F. Marshall, M.D. 2 
Richard C. Mulligan, Ph.D. 1,3 
William G. Nelson, M.D., Ph.D. 1,2 
Albert H. Owens, Jr., M.D. 1 
Drew M. Pardoll , M.D., Ph.D. 1 
Gordon Parry, Ph.D. 5 
Alan H. Partin, M.D. , Ph.D. 2 
Steven Piantadosi, M.D., Ph.D. 1 
Jonathan W. Simons, M.D. 1,2,6 , Principal Investigator 
James R. Zabora, M.S.W. 1 
1. The Johns Hopkins Oncology Center 
600 North Wolfe Street 
Baltimore, MD 21205 
(410)955-3300 
2. The James Buchanan Brady 
Urological Institute 
600 North Wolfe Street 
Baltimore, MD 21205 
(410)955-1038 
3. The Whitehead Institute for 
Biomedical Research, and 
Massachusetts Institute of 
Technology 
9 Cambridge Center 
Cambridge, MA 02142 
(617)258-5161 
[286] 
4. The Johns Hopkins University 
School of Medicine 
Department of Pathology 
600 North Wolfe Street 
Baltimore, MD 21205 
(410)955-3580 
5. Somatix Therapy Corporation 
850 Marina Village Parkway 
Alameda, CA 94501 
(510)748-3000 
6. Principal Investigator’s Office 
409 Marburg Building 
Brady Urological Institute 
The Johns Hopkins Oncology Center 
600 North Wolfe Street 
Baltimore, MD 21287-2411 
Tel: (410)614-1662 
Fax: (410)955-0833 
Recombinant DNA Research, Volume 17 
